Cogent Biosciences Inc.

NASDAQ: COGT · Real-Time Price · USD
11.88
0.17 (1.45%)
At close: Aug 15, 2025, 3:59 PM
11.89
0.08%
After-hours: Aug 15, 2025, 05:29 PM EDT

Cogent Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-284.08M -269.5M -255.86M -242.3M -227.04M -212.17M -192.41M -177.66M -157.34M -148.19M -140.24M -125.53M -109.56M -91.18M -72.27M -58.7M -89.6M -80.44M
Depreciation & Amortization
4.5M 4.42M 4.35M 4.04M 3.79M 3.93M 3.59M 3.73M 6.59M 6.53M 5.88M 5.01M 1.35M 199K 147K 96K 170K 442K
Stock-Based Compensation
40.06M 40.35M 39.74M 38.61M 37.01M 34.16M 30.62M 26.81M 22.67M 20.04M 18.37M 17.18M 16.02M 14.08M 11.69M 8.7M 8.75M 7.03M
Other Working Capital
7.73M 11.54M 10.24M 12.48M 9.35M 1.56M 6.63M 7.5M -4.14M -1.73M -1.12M -5.07M 1.5M -2.53M -731K -1.31M -2.19M -4.04M
Other Non-Cash Items
236K -7.18M -1M -2.69M 12.18M 8.86M 895K 2.65M -6.87M -6.66M -136K 27.1M 29.16M 30.62M 26.5M 2.32M 46.44M 44.97M
Deferred Income Tax
n/a n/a n/a 7.76M n/a n/a n/a -7.76M n/a n/a n/a -24.7M -24.7M -24.7M -24.7M -23K -7.49M -7.49M
Change in Working Capital
15.38M 10.12M 11.6M 17.67M 11.17M 12.96M 11.44M 13.28M -473K -2.06M 751K -5.81M 2.51M 1.17M 2.02M 2.4M -833K -4.35M
Operating Cash Flow
-233.61M -221.77M -207.79M -191.28M -177.27M -166.64M -153.62M -138.96M -135.43M -129.82M -118.64M -110.01M -89.68M -75.73M -58.76M -47.35M -43.51M -39.32M
Capital Expenditures
-1.03M -1.05M -573K -813K -654K -1.76M -2.8M -4.45M -7.64M -7.53M -6.86M -5.33M -3.18M -2.16M -1.72M -966K 197K 320K
Cash Acquisitions
n/a n/a n/a -10.8K 79.61K 156.01K 95.03K -148.13M -148.22M -148.29M -148.23M n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-100.08M -182.59M -255.6M -293.79M -386.8M -362.8M -348.8M -327.51M -363.27M -236.87M -177.85M -148.23M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
301.25M 290.25M 294.45M 281.7M 223.82M 207.9M 253.78M 252.06M 230M 180M 60M n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a 1.11M 1.12M 1.03M 957.99K -95.03K 148.13M 148.07M 148.15M 148.08M -148.23K n/a n/a n/a -320K 8.1M 8.1M
Investing Cash Flow
200.15M 106.61M 38.28M -12.91M -163.63M -156.66M -97.82M -79.9M -140.91M -64.39M -124.72M -153.56M -3.18M -2.16M -1.72M -966K 8.62M 8.74M
Debt Repayment
47.22M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
214.19M 214.19M 213.83M 1.78M 2.78M 2.88M 2.97M 1.86M 1.85M 163.87M 163.56M 163.24M 162.31M 193K -30K 47K 109.92M 109.98M
Financial Cash Flow
72.85M 25.36M 214.45M 214.43M 214.8M 377.15M 163.54M 163.85M 163.84M 163.87M 163.56M 201.25M 200.31M 38.2M 37.98M 122.11M 231.98M 232.04M
Net Cash Flow
39.38M -89.8M 44.94M 10.23M -126.1M 53.85M -87.91M -55.01M -112.5M -30.35M -79.8M -62.32M 107.46M -39.69M -22.51M 73.47M 196.76M 201.13M
Free Cash Flow
-234.65M -222.82M -208.36M -192.1M -177.93M -168.4M -156.42M -143.41M -143.07M -137.35M -125.5M -115.34M -92.86M -77.89M -60.48M -48.32M -43.31M -39M